Breder S, Villard C, Eide E, Wang B, Engesæter LK, Reims HM, Hov JR, Melum E, Aabakken L, Line PD, Lømo J, Grzyb K, Wiencke K, Bergquist A, Folseraas T(2025) A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits JHEP Rep, 7(12), 101598 DOI 10.1016/j.jhepr.2025.101598, PubMed 41321929
Del Zompo F, Crouchet E, Ostyn T, Nehme Z, Messé M, Jühling F, Désert R, Vieira AT, Moehlin J, Nakib D, Andrews T, Perciani C, Chung S, Bader GD, McGilvray I, Caime C, Scaravaglio M, Carbone M, Invernizzi P, Yaqub S, Folseraas T, Karlsen TH, Shankar G, Primeaux M, Dhawan Pet al.(2025) Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis J Hepatol, 83(6), 1305-1319 DOI 10.1016/j.jhep.2025.08.005, PubMed 40846184
ElAbd H, Pesesky M, Innocenti G, Chung BK, Mahdy AKH, Kriukova V, Kulsvehagen L, Strobbe D, Stühler C, Mayr G, May DH, Prinzensteiner M, Steiert TA, Tran F, Hadjihannas MV, Günther R, Rosati E, Mucha S, Lieb W, Ziemann M, Dempfle A, Braun F, Folseraas T, Hov JR, Melum Eet al.(2025) T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis Nat Med, 31(7), 2306-2316 DOI 10.1038/s41591-025-03692-w, PubMed 40500415